Ketoconazole (Systemic)
contraindicatedKetoconazole inhibits CYP3A4 metabolism of cisapride, causing dangerous cisapride accumulation and fatal QT prolongation/ventricular arrhythmias.
Management: NEVER combine. Use alternative prokinetic (metoclopramide) or alternative antifungal (fluconazole has less CYP3A4 inhibition).
Itraconazole
contraindicatedItraconazole inhibits CYP3A4 metabolism of cisapride, causing QT prolongation and potentially fatal ventricular arrhythmias.
Management: NEVER combine. Use metoclopramide as alternative prokinetic.
Erythromycin
contraindicatedErythromycin inhibits CYP3A4 metabolism of cisapride + erythromycin itself prolongs QT: severe QT prolongation and torsades de pointes risk.
Management: NEVER combine. Use metoclopramide as alternative prokinetic, or use different antibiotic.
Clarithromycin
contraindicatedClarithromycin potently inhibits CYP3A4 metabolism of cisapride, causing dangerous QT prolongation and torsades de pointes.
Management: NEVER combine. Use metoclopramide as alternative prokinetic.
Posaconazole
contraindicatedCYP3A4 inhibition by posaconazole causes cisapride accumulation and fatal QT prolongation.
Management: NEVER combine.
Voriconazole
contraindicatedCYP3A4 inhibition causes cisapride accumulation and fatal cardiac arrhythmias.
Management: NEVER combine. Use metoclopramide as alternative prokinetic.